+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Treatment of steroid-resistant post-transplant nephrotic syndrome with cyclophosphamide in a child with congenital nephrotic syndrome



Treatment of steroid-resistant post-transplant nephrotic syndrome with cyclophosphamide in a child with congenital nephrotic syndrome



Pediatric Nephrology 6(6): 553-555



A child with congenital nephrotic syndrome underwent renal transplantation, was treated for acute rejection, and then developed nephrotic syndrome and renal failure. He was felt to have minimal change disease on allograft biopsy, but failed to respond to therapy with corticosteroids. Cyclophosphamide was substituted for cyclosporine and rapidly induced a complete remission of his nephrotic syndrome. We feel that this case not only represents an important example of a useful therapeutic approach to the child with congenital nephrotic syndrome who develops nephrotic syndrome post transplantation, and also raises questions concerning the pathogenesis of congenital nephrotic syndrome.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 034071419

Download citation: RISBibTeXText

PMID: 1482645

DOI: 10.1007/bf00866503


Related references

FK 506 in the management of transplant-related nephrotic syndrome and steroid-resistant nephrotic syndrome. Transplantation Proceedings 23(6): 3354-3356, 1991

Treatment with Cyclophosphamide for steroid-resistant nephrotic syndrome in children. Maedica 5(3): 167-170, 2010

Initial steroid sensitivity in children with steroid-resistant nephrotic syndrome predicts post-transplant recurrence. Journal of the American Society of Nephrology 25(6): 1342-1348, 2014

Treatment of childhood steroid-resistant nephrotic syndrome with pulse methylprednisolone and cyclophosphamide. Pediatric Nephrology 10(2): 250, 1996

Comparison of cyclophosphamide and cyclosporine in the treatment of steroid-resistant idiopathic nephrotic syndrome in children. Zhong Nan Da Xue Xue Bao. Yi Xue Ban 32(6): 958-963, 2007

NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence. Kidney International 66(2): 571-579, 2004

Cyclophosphamide in steroid resistant nephrotic syndrome. Cocuk Sagligi ve Hastaliklari Dergisi 34(1): 19-24, 1991

Efficacy of intravenous pulse cyclophosphamide treatment versus combination of intravenous dexamethasone and oral cyclophosphamide treatment in steroid-resistant nephrotic syndrome. Pediatric Nephrology 23(9): 1495-1502, 2008

Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome. Kidney International 82(10): 1130-1135, 2012

Steroid-dependent nephrotic syndrome following renal transplantation for congenital nephrotic syndrome. Pediatric Nephrology 5(3): 300-303, 1991

Intravenous cyclophosphamide in steroid-resistant nephrotic syndrome. Pediatric Nephrology 18(4): 351-356, 2003

A new therapy of steroid- and cyclophosphamide-resistant adult nephrotic syndrome. Journal of the American Society of Nephrology 14(Abstracts Issue): 799A, 2003

Recurrence of nephrotic syndrome following kidney transplantation in a child with congenital nephrotic syndrome. Saudi Journal of Kidney Diseases and Transplantation 27(1): 150-152, 2016

Nephrotic syndrome: Genetic screening in steroid-resistant nephrotic syndrome. Nature Reviews Nephrology 9(7): 379-381, 2013

Mycophenolate mofetil in children with steroid/cyclophosphamide-resistant nephrotic syndrome. Pediatric Nephrology 25(3): 453-460, 2010